{
    "relation": [
        [
            "",
            "No Lifestyle Modification and Placebo",
            "Lifestyle Modification and Placebo",
            "No Lifestyle Modification and Metformin",
            "Lifestyle Modification and Metformin"
        ],
        [
            "Description",
            "Participants did not participate in lifestyle modification and took a placebo capsule 500mg twice daily x 3 months, which was increased to 850mg twice daily at the 3 month visit for the duration of the study.",
            "Participants participated in lifestyle modification sessions 3 times a week for the duration of the study and took a placebo capsule 500mg twice daily for 3 months which was increased to 850mg twice daily at the 3 month visit for the duration of the study.",
            "Participants did not participate in lifestyle modification and took metformin 500mg twice daily for 3 months, this was increased to 850mg twice daily at the 3 month visit for the duration of the study.",
            "Participants participated in lifestyle modification sessions 3 times a week for the duration of the study and took metformin 500mg twice daily for 3 months which was increased to 850mg twice daily at the 3 month visit for the duration of the study."
        ]
    ],
    "pageTitle": "Lifestyle Modification and Metformin Use in the Treatment of HIV - Study Results - ClinicalTrials.gov",
    "title": "",
    "url": "https://clinicaltrials.gov/ct2/show/results/NCT00399360?sect=X01256&view=results",
    "hasHeader": true,
    "headerPosition": "MIXED",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042992201.62/warc/CC-MAIN-20150728002312-00251-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 866508392,
    "recordOffset": 866487554,
    "tableOrientation": "HORIZONTAL",
    "textBeforeTable": "Reporting Groups No text entered. Significant events and approaches for the overall study following participant enrollment, but prior to group assignment Pre-Assignment Details No text entered. Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations Recruitment Details \u00a0 Hide Participant Flow \u00a0 Participant Flow Drug: Metformin Drug: Placebo Behavioral: Lifestyle Modification Interventions: HIV Infections Metabolic Syndrome X Conditions: Allocation:\u00a0Randomized; \u00a0 Intervention\u00a0Model:\u00a0Factorial\u00a0Assignment; \u00a0 Masking:\u00a0Double\u00a0Blind\u00a0(Subject,\u00a0Caregiver,\u00a0Investigator,\u00a0Outcomes\u00a0Assessor); \u00a0 Primary\u00a0Purpose:\u00a0Treatment Study Design: Interventional Study Type: Results First Received: May 18, 2012 \u00a0",
    "textAfterTable": "Participant Flow: \u00a0 Overall Study \u00a0 \u00a0 No Lifestyle Modification and Placebo \u00a0 \u00a0 Lifestyle Modification and Placebo \u00a0 \u00a0 No Lifestyle Modification and Metformin \u00a0 \u00a0 Lifestyle Modification and Metformin \u00a0 STARTED \u00a0 \u00a0 11 \u00a0 \u00a0 11 \u00a0 \u00a0 13 \u00a0 \u00a0 15 \u00a0 COMPLETED \u00a0 \u00a0 9 \u00a0 \u00a0 8 \u00a0 \u00a0 10 \u00a0 \u00a0 9 \u00a0 NOT COMPLETED \u00a0 \u00a0 2 \u00a0 \u00a0 3 \u00a0 \u00a0 3 \u00a0 \u00a0 6 \u00a0 Lost to Follow-up \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 2 \u00a0 \u00a0",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}